Neurocrine Biosciences (NBIX)Chief Regulatory Officer sold ~$62K
Ingrid Delaet, Chief Regulatory Officer at Neurocrine Biosciences, sold ~$62K of Neurocrine Biosciences shares.
- ~$62K
- Approx. value · 457 sh @ $135.00
- 4,730
- Holds after · shares reported
- Traded
- Jul 10, 2025
- Filed
- Jul 11, 2025
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- May 27, 2025InsiderDirector sold ~$1.16M of NBIX shares in the open market
- Jun 11, 2025CongressDisclosed purchase of NBIX — reported range $1,001 - $15,000
- Jun 17, 2025CongressDisclosed partial sale of NBIX — reported range $1,001 - $15,000
- Jul 2, 2025InsiderOfficer sold ~$2.65M of NBIX shares in the open market
- Jul 9, 2025InsiderOfficer sold ~$7.8M of NBIX shares in the open market
- Jul 10, 2025 · this disclosureInsiderOfficer sold ~$62K of NBIX shares in the open market
What came next
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Neurocrine Biosciences
For Neurocrine Biosciences, OQRO holds 13 fund holdings reports (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its NBIX page.
Other recent filings by Ingrid Delaet, Chief Regulatory Officer
- SEC Form 4 at Neurocrine Biosciences (NBIX)Feb 14, 2025
- SEC Form 4 at Neurocrine Biosciences (NBIX)Feb 14, 2025
- SEC Form 4 at Neurocrine Biosciences (NBIX)Feb 4, 2025
- SEC Form 4 at Neurocrine Biosciences (NBIX)Feb 4, 2025
- SEC Form 4 at Neurocrine Biosciences (NBIX)Jan 3, 2025
The full history of Ingrid Delaet, Chief Regulatory Officer is on the profile page.
How this filing works
Other disclosures at Neurocrine Biosciences
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
Everything OQRO holds on this company is on its NBIX page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
